GEHC Cash Per Share vs Price To Sales Ratio Analysis

GEHC Stock

82.79 0.43 0.52%

GE HealthCare financial indicator trend analysis is much more than just examining GE HealthCare Techno latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether GE HealthCare Techno is a good investment. Please check the relationship between GE HealthCare Cash Per Share and its Price To Sales Ratio accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GE HealthCare Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Cash Per Share vs Price To Sales Ratio

Cash Per Share vs Price To Sales Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of GE HealthCare Techno Cash Per Share account and Price To Sales Ratio. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between GE HealthCare's Cash Per Share and Price To Sales Ratio is -0.3. Overlapping area represents the amount of variation of Cash Per Share that can explain the historical movement of Price To Sales Ratio in the same time period over historical financial statements of GE HealthCare Technologies, assuming nothing else is changed. The correlation between historical values of GE HealthCare's Cash Per Share and Price To Sales Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash Per Share of GE HealthCare Technologies are associated (or correlated) with its Price To Sales Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Price To Sales Ratio has no effect on the direction of Cash Per Share i.e., GE HealthCare's Cash Per Share and Price To Sales Ratio go up and down completely randomly.

Correlation Coefficient

-0.3

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Cash Per Share

Price To Sales Ratio

Price to Sales Ratio is figured by comparing GE HealthCare Techno stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on GE HealthCare sales, a figure that is much harder to manipulate than other GE HealthCare Technologies multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Most indicators from GE HealthCare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into GE HealthCare Techno current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GE HealthCare Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

As of December 11, 2024, Tax Provision is expected to decline to about 653 M. In addition to that, Discontinued Operations is expected to decline to about 15.4 M

	2021	2022	2023	2024 (projected)
Interest Expense	40M	77M	542M	569.1M
Depreciation And Amortization	625M	633M	610M	513.9M

Interest Expense Depreciation And Amortization

GE HealthCare fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Non Current Liabilities Total	Capital Lease Obligations	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab
Common Stock Shares Outstanding		0.56	0.33	0.51	0.53	-0.46	-0.65	-0.52	0.75	0.88	0.33	0.52	0.3	0.61	0.32	0.42	0.32	0.3	0.48	0.77	0.34	-0.87	0.53	0.35	0.26	0.38
Total Assets	0.56		0.9	0.89	0.99	-0.89	-0.96	-0.88	0.96	0.85	0.89	0.93	0.85	0.98	0.92	0.86	0.87	0.85	0.93	0.87	0.93	-0.67	0.83	0.51	0.63	0.95
Short Long Term Debt Total	0.33	0.9		0.73	0.89	-0.97	-0.85	-0.96	0.83	0.69	1.0	0.92	0.89	0.82	0.91	0.86	1.0	0.89	0.86	0.71	0.99	-0.54	0.82	0.71	0.86	0.98
Other Current Liab	0.51	0.89	0.73		0.95	-0.79	-0.75	-0.68	0.88	0.67	0.69	0.66	0.9	0.94	0.93	0.93	0.67	0.9	0.65	0.62	0.82	-0.39	0.49	0.11	0.3	0.84
Total Current Liabilities	0.53	0.99	0.89	0.95		-0.91	-0.9	-0.85	0.95	0.8	0.87	0.87	0.91	0.99	0.96	0.93	0.85	0.91	0.85	0.79	0.94	-0.57	0.73	0.41	0.57	0.96
Total Stockholder Equity	-0.46	-0.89	-0.97	-0.79	-0.91		0.82	0.97	-0.88	-0.74	-0.96	-0.87	-0.93	-0.85	-0.92	-0.93	-0.96	-0.93	-0.78	-0.69	-0.97	0.56	-0.74	-0.64	-0.8	-0.97
Other Liab	-0.65	-0.96	-0.85	-0.75	-0.9	0.82		0.87	-0.94	-0.92	-0.86	-0.97	-0.69	-0.92	-0.78	-0.71	-0.84	-0.69	-0.97	-0.97	-0.85	0.82	-0.94	-0.65	-0.69	-0.87
Net Tangible Assets	-0.52	-0.88	-0.96	-0.68	-0.85	0.97	0.87		-0.88	-0.81	-0.97	-0.93	-0.83	-0.81	-0.83	-0.82	-0.97	-0.83	-0.85	-0.79	-0.94	0.7	-0.86	-0.8	-0.89	-0.93
Property Plant And Equipment Net	0.75	0.96	0.83	0.88	0.95	-0.88	-0.94	-0.88		0.94	0.82	0.88	0.81	0.97	0.85	0.85	0.81	0.81	0.86	0.9	0.86	-0.77	0.8	0.51	0.59	0.89
Current Deferred Revenue	0.88	0.85	0.69	0.67	0.8	-0.74	-0.92	-0.81	0.94		0.7	0.86	0.56	0.84	0.62	0.63	0.69	0.56	0.83	0.96	0.69	-0.94	0.85	0.62	0.59	0.71
Net Debt	0.33	0.89	1.0	0.69	0.87	-0.96	-0.86	-0.97	0.82	0.7		0.94	0.86	0.81	0.88	0.82	1.0	0.86	0.88	0.73	0.98	-0.56	0.85	0.75	0.89	0.97
Accounts Payable	0.52	0.93	0.92	0.66	0.87	-0.87	-0.97	-0.93	0.88	0.86	0.94		0.71	0.85	0.78	0.7	0.92	0.71	0.98	0.91	0.9	-0.78	0.97	0.78	0.83	0.9
Cash	0.3	0.85	0.89	0.9	0.91	-0.93	-0.69	-0.83	0.81	0.56	0.86	0.71		0.84	0.98	0.99	0.86	1.0	0.65	0.51	0.94	-0.29	0.52	0.34	0.58	0.94
Non Current Assets Total	0.61	0.98	0.82	0.94	0.99	-0.85	-0.92	-0.81	0.97	0.84	0.81	0.85	0.84		0.91	0.88	0.79	0.84	0.86	0.84	0.88	-0.63	0.74	0.37	0.49	0.9
Non Currrent Assets Other	0.32	0.92	0.91	0.93	0.96	-0.92	-0.78	-0.83	0.85	0.62	0.88	0.78	0.98	0.91		0.97	0.87	0.98	0.75	0.61	0.96	-0.36	0.61	0.36	0.57	0.97
Other Assets	0.42	0.86	0.86	0.93	0.93	-0.93	-0.71	-0.82	0.85	0.63	0.82	0.7	0.99	0.88	0.97		0.82	0.99	0.64	0.55	0.91	-0.36	0.52	0.31	0.53	0.92
Long Term Debt	0.32	0.87	1.0	0.67	0.85	-0.96	-0.84	-0.97	0.81	0.69	1.0	0.92	0.86	0.79	0.87	0.82		0.86	0.86	0.71	0.97	-0.56	0.84	0.76	0.9	0.96
Cash And Short Term Investments	0.3	0.85	0.89	0.9	0.91	-0.93	-0.69	-0.83	0.81	0.56	0.86	0.71	1.0	0.84	0.98	0.99	0.86		0.65	0.51	0.94	-0.29	0.52	0.34	0.58	0.94
Net Receivables	0.48	0.93	0.86	0.65	0.85	-0.78	-0.97	-0.85	0.86	0.83	0.88	0.98	0.65	0.86	0.75	0.64	0.86	0.65		0.92	0.85	-0.75	0.96	0.7	0.74	0.86
Good Will	0.77	0.87	0.71	0.62	0.79	-0.69	-0.97	-0.79	0.9	0.96	0.73	0.91	0.51	0.84	0.61	0.55	0.71	0.51	0.92		0.7	-0.93	0.93	0.66	0.62	0.72
Non Current Liabilities Total	0.34	0.93	0.99	0.82	0.94	-0.97	-0.85	-0.94	0.86	0.69	0.98	0.9	0.94	0.88	0.96	0.91	0.97	0.94	0.85	0.7		-0.5	0.77	0.6	0.77	1.0
Capital Lease Obligations	-0.87	-0.67	-0.54	-0.39	-0.57	0.56	0.82	0.7	-0.77	-0.94	-0.56	-0.78	-0.29	-0.63	-0.36	-0.36	-0.56	-0.29	-0.75	-0.93	-0.5		-0.85	-0.71	-0.6	-0.51
Inventory	0.53	0.83	0.82	0.49	0.73	-0.74	-0.94	-0.86	0.8	0.85	0.85	0.97	0.52	0.74	0.61	0.52	0.84	0.52	0.96	0.93	0.77	-0.85		0.84	0.83	0.77
Other Current Assets	0.35	0.51	0.71	0.11	0.41	-0.64	-0.65	-0.8	0.51	0.62	0.75	0.78	0.34	0.37	0.36	0.31	0.76	0.34	0.7	0.66	0.6	-0.71	0.84		0.95	0.57
Other Stockholder Equity	0.26	0.63	0.86	0.3	0.57	-0.8	-0.69	-0.89	0.59	0.59	0.89	0.83	0.58	0.49	0.57	0.53	0.9	0.58	0.74	0.62	0.77	-0.6	0.83	0.95		0.75
Total Liab	0.38	0.95	0.98	0.84	0.96	-0.97	-0.87	-0.93	0.89	0.71	0.97	0.9	0.94	0.9	0.97	0.92	0.96	0.94	0.86	0.72	1.0	-0.51	0.77	0.57	0.75

Click cells to compare fundamentals

GE HealthCare Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

When determining whether GE HealthCare Techno offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of GE HealthCare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ge Healthcare Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ge Healthcare Technologies Stock:

How To Invest In GEHC

Details

Is GEHC Stock a good investment?

Details

What is GE HealthCare's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GE HealthCare Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GE HealthCare. If investors know GEHC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GE HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.242

Dividend Share

0.12

Earnings Share

3.65

Revenue Per Share

42.916

Quarterly Revenue Growth

0.009

The market value of GE HealthCare Techno is measured differently than its book value, which is the value of GEHC that is recorded on the company's balance sheet. Investors also form their own opinion of GE HealthCare's value that differs from its market value or its book value, called intrinsic value, which is GE HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GE HealthCare's market value can be influenced by many factors that don't directly affect GE HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between GE HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if GE HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GE HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

GEHC Cash Per Share vs Price To Sales Ratio Analysis

Cash Per Share vs Price To Sales Ratio

Cash Per Share vs Price To Sales Ratio Correlation Analysis

Correlation Coefficient

Cash Per Share

Price To Sales Ratio

GE HealthCare fundamental ratios Correlations

GE HealthCare Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Debt	+ 1.0	Short Long Term Debt Total
Long Term Debt	+ 1.0	Short Long Term Debt Total
Long Term Debt	+ 1.0	Net Debt
Cash And Short Term Investments	+ 1.0	Cash
Total Liab	+ 1.0	Non Current Liabilities Total
Total Current Liabilities	+ 0.99	Total Assets

Long Term Debt	- 0.97	Net Tangible Assets
Net Debt	- 0.97	Net Tangible Assets
Good Will	- 0.97	Other Liab
Net Receivables	- 0.97	Other Liab
Accounts Payable	- 0.97	Other Liab
Total Liab	- 0.97	Total Stockholder Equity